Brooks Biocision Cryopod™ Portable Liquid Nitrogen Transport Container
| Brand | AZENTA (formerly Brooks Life Sciences) |
|---|---|
| Origin | USA |
| Manufacturer Type | Authorized Distributor |
| Product Origin | Imported |
| Model | Biocision Cryopod™ |
| Price Range | USD $2,500 – $6,200 |
Overview
The Brooks Biocision Cryopod™ is an engineered portable liquid nitrogen (LN₂) transport container designed for the secure, temperature-stable transit of cryopreserved biological specimens—including viable cells, stem cell lines, oocytes, embryos, and tissue biobank samples—at sustained temperatures below −150 °C for up to 4.5 hours. Unlike passive dry shippers relying solely on vapor-phase insulation, the Cryopod™ employs an actively monitored, vacuum-insulated double-walled stainless-steel architecture with a precisely regulated LN₂ reservoir. Its thermal management system maintains consistent ultra-low temperatures without direct sample immersion in liquid nitrogen—eliminating risks of cross-contamination, thermal shock, or vial fracture during handling. The device integrates real-time temperature sensing at multiple internal zones (sample chamber, vapor space, and reservoir), enabling continuous validation of cold chain integrity throughout transport, transfer, or short-term staging prior to long-term storage in stationary LN₂ tanks.
Key Features
- Vacuum-jacketed stainless-steel construction with validated thermal hold time ≥4.5 hr at <−150 °C (per ISO 13485–aligned qualification protocols)
- Integrated high-resolution digital display showing real-time temperature (±0.3 °C accuracy), date, and timestamp; data logged internally at user-selectable intervals (1–60 min)
- Dual-stage audible/visual alarm system triggered by temperature excursion (>−150 °C threshold), low LN₂ level (<15% remaining), or lid-open event
- Ergonomic design: net weight ≈ 4.1 kg (9 lb); footprint < 20 cm × 20 cm; features recessed top handle and under-grip finger grooves for one-handed stability and safe lifting
- Optional integration with Biocision AutoFill™ Station: enables hands-free, programmable LN₂ replenishment in ≤14 minutes with flow-rate control and auto-shutoff at preset fill level
- Sample compartment configured for standard 2 mL cryovials (up to 48 vials in 2×24 rack format) or 0.5 mL straws; no direct contact between samples and bulk LN₂—samples reside exclusively in stable vapor-phase environment
Sample Compatibility & Compliance
The Cryopod™ is compatible with all commonly used cryogenic containers, including externally threaded 2 mL vials (e.g., Nunc™, Thermo Scientific™), cryo-straws (0.25–0.5 mL), and pre-loaded cryoboxes. It conforms to key regulatory expectations for specimen transport under Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) frameworks. Temperature logging meets FDA 21 CFR Part 11 requirements when paired with Biocision’s validated software suite (CryoLog™ v3.2+), supporting electronic signatures, audit trails, and exportable CSV/PDF reports. Device qualification documentation—including IQ/OQ protocols, thermal mapping reports, and alarm response verification—is provided per customer request and aligns with ISO/IEC 17025 and AABB standards for biologics handling.
Software & Data Management
Temperature and event logs are stored onboard in non-volatile memory (≥10,000 entries). Data retrieval is performed via USB-C interface using CryoLog™ Desktop Software (Windows 10/11), which supports batch export, trend visualization, annotation tagging, and automated report generation compliant with ISO 15189 and CAP checklist TRK.42500. All log files include cryptographic hash verification to ensure data integrity. When deployed in networked lab environments, optional Wi-Fi-enabled gateway modules enable remote status monitoring and push notifications via secure TLS 1.2–encrypted MQTT channels—fully auditable within enterprise LIMS integrations.
Applications
- Inter-facility transport of clinical-grade CAR-T cells and hematopoietic stem cells between manufacturing suites and infusion centers
- On-site embryo transfer logistics in assisted reproductive technology (ART) clinics requiring uninterrupted −150 °C maintenance
- Field collection and stabilization of rare biospecimens (e.g., tumor biopsies, PBMCs) in multi-center clinical trials
- Temporary staging of QC-release samples awaiting final characterization in central testing laboratories
- Backup transport solution during scheduled maintenance or emergency outage of primary liquid nitrogen storage infrastructure
FAQ
What is the validated hold time at −150 °C, and under what ambient conditions?
The Cryopod™ achieves ≥4.5 hours at <−150 °C when starting fully filled with LN₂ and tested at 23 °C ambient, 50% RH, per ASTM F2626–22 Annex A1.
Does the device support GLP-compliant electronic records?
Yes—when used with CryoLog™ v3.2+ and enabled audit trail configuration, it satisfies FDA 21 CFR Part 11 requirements for electronic records and signatures.
Can the Cryopod™ be used for long-term storage?
No—it is expressly designed for short-duration transport and staging only; extended storage requires stationary liquid nitrogen tanks qualified per ISO 20578.
Is training and qualification support available for laboratory personnel?
AZENTA provides on-site or virtual IQ/OQ execution support, SOP development assistance, and operator competency assessment tools upon request.
How frequently must the unit undergo recalibration?
Temperature sensors are factory-calibrated traceable to NIST standards; annual verification is recommended using certified dry-block calibrators per ISO/IEC 17025 guidelines.

